Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
Acq. announced
Director departure
Appointed director
ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/18/2007 8-K/A Acquisition/merger/asset purchase announced
Docs: "AND AGREES TO CAUSE ITS AFFILIATES TO WAIVE, ALL RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.",
"Gene Logic Agrees to Sell Genomics Assets Reinforced Commitment to Drug Repositioning and Development Business GAITHERSBURG, Md.--(BUSINESS WIRE)--Oct. 15, 2007--Gene Logic Inc."
10/18/2007 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Advisory Services Agreement between Gene Logic Inc. and Louis Tartaglia"
07/12/2007 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Charles L. Dimmler, III employment agreement, signed July 9, 2007"
05/01/2007 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
05/01/2007 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
02/23/2005 8-K/A Director compensation was amended/approved
Docs: "EXHIBIT 10.6a Summary of Non-Employee Director Compensation"
07/31/2003 8-K/A Financial statements and exhibits
Docs: "Consent of Reznick Fedder & Silverman, Independent Auditors",
"Unaudited financial statements of TherImmune Research Corporation as of March 31, 2003 and for the three months ended March 31, 2003 and 2002, including notes thereto",
"Unaudited pro forma balance sheet as of March 31, 2003 and unaudited pro forma statement of operations for the three months ended March 31, 2003, including notes thereto"
06/02/2003 8-K/A Financial statements and exhibits
Docs: "Consent of Reznick Fedder & Silverman, Independent Auditors",
"Audited financial statements of TherImmune Research Corporation as of December 31, 2002 and for the year then ended, including notes thereto",
"Unaudited pro forma balance sheet as of December 31, 2002 and unaudited pro forma statement of operations for the year ended December 31, 2002, including notes thereto"
05/12/2000 8-K/A Changes in registrant's certifying accountant
05/04/2000 8-K/A Changes in registrant's certifying accountant, Financial statements and exhibits

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy